DOCSLIB.ORG

Revista2vol87ingle Snaza Layout 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Revista2vol87ingle Snaza Layout 1 REVIEW 277 ▲ Pyodermitis * Piodermites Júlio César Empinotti 1 Hirofumi Uyeda 2 Roseli Terezinha Ruaro 3 Ana Paula Galhardo 4 Danielle Cristine Bonatto 4 Abstract: Pyodermitis are primary skin infections mainly caused by pyogenic bacteria of the Staphylococcus and Streptococcus genera. They are relatively common diseases that affect adults and children. There have been fre- quent reports of bacterial resistance to the recommended antibiotics over the last few years; however, new subs- tances are in use or under development, and this represents an evolution in the treatment of pyodermitis. This review aims at describing clinical, diagnostic and therapeutical features of major pyodermitis: impetigo, ecthyma, erysipelas, staphylococcal scalded skin syndrome and folliculitis. Keywords: Bacterial infections; Review; Staphylococcus; Streptococcus; Skin infections staphylococcal Resumo: As piodermites são infecções cutâneas primárias originadas principalmente por bactérias piogênicas dos gêneros Staphylococcus e Streptococcus. Tratam-se de doenças relativamente comuns, que acometem adul- tos e crianças. Nos últimos anos há relatos freqüentes de resistência bacteriana aos antibióticos preconizados, no entanto, novas substâncias estão em uso ou mesmo em desenvolvimento, o que representa uma evolução na terapia das piodermites. Esta revisão tem como objetivo descrever aspectos clínicos, diagnósticos e terapêuticos das principais Piodermites: impetigo, ectima, erisipela, síndrome da pele escaldada estafilocócica e foliculites. Palavras-chave: Infecções bacterianas; Infecções cutâneas estafilocócicas; Revisão; Staphylococcus; Streptococcus INTRODUCTION The skin has resident bacteria, which live as Staphylococcus aureus (coagulase- positive) and by commensal bacteria, and transient bacteria, which can Streptococcus pyogenes. These bacteria, originating occasionally colonize the skin. The resident flora con- from the environment, show pathogenicity usually in sists mainly of Gram-positive cocci (Staphylococcus the presence of a disturbance of skin integrity. 1 epidermidis), diphtheroids (Corynebacterium and Pyodermitis are defined as primary skin infec- Brevibacterium) and anaerobic rods (Propioni - tions caused mainly by pyogenic bacteria of the bacterium). The organisms of the resident flora contri- Staphylococcus and Streptococcus genera. 3 bute to resistance against colonization with pathoge- Among staphylococci, Staphylococcus aureus nic bacteria by hydrolyzing lipids and producing free (S. aureus) is the most important pathogen, causing fatty acids, which are toxic to many bacteria. 1,2 superficial or deep infections and diseases related to The transient flora is mainly represented by the action of their toxins. The skin is the natural habi- Received on 19.04.2011. Approved by the Advisory Board and accepted for publication on 13.07.2011. * Work conducted at Universidade Estadual do Oeste do Paraná - UNIOESTE, Cascavel Parana, Brazil. Conflict of interest: None Financial Support: None 1 PhD – Professor of Dermatology, Universidade Estadual do Oeste do Paraná - UNIOESTE - Cascavel (PR), Brazil. 2 Dermatologist, Associate Member of the Brazilian Society of Dermatology - Assistant Professor of Medicine, Universidade Estadual do Oeste do Paraná - UNIOESTE - Cascavel (PR), Brazil. 3 Dermatologist, Associate Member of the Brazilian Society of Dermatology - Collaborator Professor of Dermatology, Medical School, Universidade Estadual do Oeste do Paraná - UNIOESTE - Cascavel (PR), Brazil. 4 Medical Student, Universidade Estadual do Oeste do Paraná - UNIOESTE - Cascavel (PR), Brazil. ©2012 by Anais Brasileiros de Dermatologia An Bras Dermatol. 2012;87(2):277-84. 278 Empinotti JC, Uyeda H, Ruaro RT, Galhardo AP, Bonatto DC tat of many species of staphylococci. There is perma- Impetigo nent colonization with S. aureus in the anterior nares Impetigo is a superficial skin infection caused of 20% of the population. Approximately 60% of healt- mainly by staphylococci and, less often, streptococci hy individuals have occasional colonization with S. or a combination of both bacteria. The disease is com- aureus somewhere in the body, especially in the axil- mon and more prevalent in children. 1 (Figure 1). la, perineum, pharynx, hands and nares. The main There are two variants of the disease: nonbul- defense against staphylococci is neutrophil phagocy- lous impetigo and bullous impetigo. Staphylococci tosis. Conditions that predispose to skin colonization have been the cause of bullous impetigo and group A due to low resistance to the agent include atopic der- streptococci are most frequently the causative orga- matitis, diabetes mellitus, dialysis, intravenous drug nisms in nonbullous impetigo. 3 use, liver dysfunction and HIV infection. Direct inva- The nonbullous variant, which accounts for sion occurring at small breaks in the mucous membra- more than 70% of cases, also known as impetigo con- nes, skin and its appendages results in a variety of tagiosa (Tilbury-Fox), begins with a thin-walled vesicle superficial infections. 1,4,5 or pustule, hardly noticeable, as it soon ruptures, Streptococci almost always participate in the sometimes on an erythematous base. The purulent microbiota of the oral or gastrointestinal tract, and exudate dries and forms the classic thick yellow- they are among the most common agents of human brown crust (meliceric). When removed, the crust diseases. Streptococcus pyogenes (S. pyogenes) is res- quickly reappears. Although exposed areas of skin are ponsible for most infections caused by bacteria of the affected more often in adults, in children any site can Streptococcaceae family, being found in the oropha- be affected. 6,7 rynx of 10% of the general population. Only 1% of In staphylococcal bullous impetigo, small individuals have it in normal skin. The most virulent breaks in the skin allow the onset of infection with the streptococci belong to group A and have the M pro- formation of blisters caused by staphylococcal exfolia- tein on their surface, which protects against phagocy- tive toxins produced on site. The disease affects chil- tosis and increases adherence to epithelial tissues. 1 dren, most often in the face and legs; however, it can Infections with S. pyogenes are more common in also involve other areas. 4 Lesions begin as erythema- childhood and adolescence. This is due to the fact that tous maculae that progress to superficial blisters with successive infections, symptomatic or unapparent, serous content. Nikolsky’s sign is not present. 1 These with prevalent serotypes in the community confer las- blisters rupture easily, leading to the formation of ting and specific immunity against this pathogen. 4 thin, smooth, honey-colored crusts, similar to a coa- The frequency of pyodermitis varies based on ting film, which, upon scaling, do not leave scars. The several factors; in general, they affect around 7% of lesions are small, multiple and in various stages of the population. The summer season favors skin infec- development. Staphylococcal bullous impetigo does tions, as it facilitates the installation and maintenance not jeopardize the general health of the individual, of the microclimate, heat and moisture necessary for and fever is only present when there are multiple the development of infectious agents. 5 lesions. Locally, there is minor discomfort and itching In the pathogenesis of pyodermitis we must may occur. 4 consider host factors: presence of resident flora which hinders the colonization with other bacteria and pro- duces unsaturated fatty acids that form a chemical bar- rier; mechanical barrier; the moisture content of the skin - the higher the moisture, the easier the bacterial multiplication; an alkaline pH that facilitates bacterial colonization, and the immune competence of the individual. With regard to the microorganism, the degree of pathogenicity and virulence is considered, which basically derives from the invasive potential determined by the presence of antiphagocytic ele- ments on the bacterial surface and the ability to pro- duce toxins. Although the etiology of pyodermitis is basical- ly the same, there are several distinct clinical forms with regard to morphology, evolution, pathogenesis, 5 complications and therapy. FIGURE 1: Impetigo An Bras Dermatol. 2012;87(2):277-84. Pyodermitis 279 In the two variants, after the vesiculobulla rup- low sensitizing power, such as mupirocin or fusidic tures and there is crust formation, central clearing acid. This approach is sufficient to clear mild to mode- and peripheral extension can lead to a circinate rate cases, since the infection is often self-limited. 3,7 lesion, mimicking superficial fungal infection. Lesions Recently, retapamulin has been revealed as a are usually asymptomatic and may sometimes show new topical antibiotic to treat cases of impetigo. mild itching or burning. There is rapid development Retapamulin is the first member of a new class of anti- of satellite lesions by contamination of other areas, by biotics called pleuromutilins. It is a semi-synthetic scratching, or where there was contact with the exu- drug, available as 1% ointment for dermatological use date. 6 only. It was approved by the FDA in April 2007 for the The appearance of lesions of impetigo, which treatment of impetigo, when the disease is caused by usually follows bruising, abrasions, minor trauma or S. aureus sensitive to methicillin or S. pyogenes; it is insect bites, occurs in people whose skin surface was recommended for topical application twice
Load more

Recommended publications
  • Bacterial Skin Infections an Observational Study
    RESEARCH Geoffrey Spurling Deborah Askew David King Geoffrey K Mitchell MBBS, DTM&H, FRACGP, is Senior PhD, is Senior Research Fellow, MBBS, MPH, FRACGP, is Senior Lecturer, MBBS, PhD, FRACGP, FAChPM, Lecturer, Discipline of General Practice, Discipline of General Practice, Discipline of General Practice, University is Associate Professor, Discipline University of Queensland. g.spurling@ University of Queensland. of Queensland. of General Practice, University of uq.edu.au Queensland. Bacterial skin infections An observational study Bacterial skin infections such as impetigo and boils are Background common, contagious, often painful, and have the potential to We aimed to determine the feasibility of measuring resolution rates of recur. They are caused by Staphylococcus aureus and bacterial skin infections in general practice. occasionally by Streptococcus pyogenes, and are transmitted Methods by skin-to-skin contact, fomite contact or contact with nasal Fifteen general practitioners recruited patients from March 2005 to carriers.1 In the United Kingdom, incidence of skin infections October 2007 and collected clinical and sociodemographic data at in children in 2005 was approximately 75 per 100 000.2 Skin baseline. Patients were followed up at 2 and 6 weeks to assess lesion infection rates are likely to be higher in warmer climates. The resolution. only Australian data we found were for one Northern Territory Results Aboriginal Medical Service (Danila Dilba), which recorded 7.5 Of 93 recruited participants, 60 (65%) were followed up at 2 and 6 per 100 consultations for localised skin infections.3 weeks: 50% (30) had boils, 37% (22) had impetigo, 83% (50) were prescribed antibiotics, and active follow up was suggested for 47% Suggested risk factors for impetigo include: household crowding, (28).
    [Show full text]
  • Current Microbiological, Clinical and Therapeutic Aspects of Impetigo Lior Zusmanovich, Lior Charach and Gideon Charach*
    ISSN: 2378-3656 Zusmanovich et al. Clin Med Rev Case Rep 2018, 5:205 DOI: 10.23937/2378-3656/1410205 Volume 5 | Issue 3 Clinical Medical Reviews Open Access and Case Reports CASE REPORT Current Microbiological, Clinical and Therapeutic Aspects of Impetigo Lior Zusmanovich, Lior Charach and Gideon Charach* Department of Internal Medicine “C”, Affiliated to Tel Aviv University, Israel *Corresponding author: Gideon Charach, Department of Internal Medicine “C”, Tel Aviv Sourasky Check for Medical Center, Sackler Medical School, Affiliated to Tel Aviv University, 6 Weizman Street, Tel Aviv updates 6423906, Israel, Tel: +972-3-6973766, Fax: +972-3-6973929, E-mail: [email protected] nonpurulent and purulent cellulitis, and treatment is Abstract based on extent of infection and risk factors. Abscesses Impetigo is a highly contagious infection of the epidermis, involve the dermis and deeper skin tissues as a result of seen especially among children, and transmitted through direct contact. Two bacteria are associated with impetigo: pus formation. S. aureus and GAS. Over 140 million people are suffering Impetigo is observed most frequently among chil- from impetigo at each time point, over 100 million are chil- dren. Two forms of impetigo exist, namely impetigo conta- dren 2-5 years of age and is transmitted through direct giosa, known as the non-bullous form and the second one contact [1]. Risk factors for impetigo include poor hy- being bullous impetigo which presents with large and fragile giene, low economic status, crowding and underlying bullae. Treatment options for impetigo include systemic an- scabies [2,3]. Important consideration is carriage of tibiotics, topical antibiotics as well as topical disinfectants.
    [Show full text]
  • Inflammatory Or Infectious Hair Disease? a Case of Scalp Eschar and Neck Lymph Adenopathy After a Tick Bite
    Case Report ISSN: 2574 -1241 DOI: 10.26717/BJSTR.2021.35.005688 Adherent Serous Crust of the Scalp: Inflammatory or Infectious Hair Disease? A Case of Scalp Eschar and Neck Lymph Adenopathy after a Tick Bite Starace M1, Vezzoni R*2, Alessandrini A1 and Piraccini BM1 1Dermatology - IRCCS, Policlinico Sant’Orsola, Department of Specialized, Experimental and Diagnostic Medicine, Alma Mater Studiorum, University of Bologna, Italy 2Dermatology Clinic, Maggiore Hospital, University of Trieste, Italy *Corresponding author: Roberta Vezzoni, Dermatology Clinic, Maggiore Hospital, University of Trieste, Italy ARTICLE INFO ABSTRACT Received: Published: April 17, 2021 The appearance of a crust initially suggests inflammatory scalp diseases, although infectious diseases such as impetigo or insect bites should also be considered among April 27, 2021 the differential diagnoses. We report a case of 40-year-old woman presentedB. Burgdorferi to our, Citation: Starace M, Vezzoni R, Hair Disease Outpatient Service with an adherent serous crust on the scalp and lymphadenopathy of the neck. Serological tests confirmed the aetiology of while rickettsia infection was excluded. Lyme borreliosis can mimic rickettsia infection Alessandrini A, Piraccini BM. Adherent and may present as scalp eschar and neck lymphadenopathy after a tick bite (SENLAT). Serous Crust of the Scalp: Inflammatory Appropriate tests should be included in the diagnostic workup of patients with necrotic or Infectious Hair Disease? A Case of Scalp scalpKeywords: eschar in order to promptly set
    [Show full text]
  • Cutaneous Adverse Effects of Biologic Medications
    REVIEW CME MOC Selena R. Pasadyn, BA Daniel Knabel, MD Anthony P. Fernandez, MD, PhD Christine B. Warren, MD, MS Cleveland Clinic Lerner College Department of Pathology Co-Medical Director of Continuing Medical Education; Department of Dermatology, Cleveland Clinic; of Medicine of Case Western and Department of Dermatology, W.D. Steck Chair of Clinical Dermatology; Director of Clinical Assistant Professor, Cleveland Clinic Reserve University, Cleveland, OH Cleveland Clinic Medical and Inpatient Dermatology; Departments of Lerner College of Medicine of Case Western Dermatology and Pathology, Cleveland Clinic; Assistant Reserve University, Cleveland, OH Clinical Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH Cutaneous adverse effects of biologic medications ABSTRACT iologic therapy encompasses an expo- B nentially expanding arena of medicine. Biologic therapies have become widely used but often As the name implies, biologic therapies are de- cause cutaneous adverse effects. The authors discuss the rived from living organisms and consist largely cutaneous adverse effects of tumor necrosis factor (TNF) of proteins, sugars, and nucleic acids. A clas- alpha inhibitors, epidermal growth factor receptor (EGFR) sic example of an early biologic medication is inhibitors, small-molecule tyrosine kinase inhibitors insulin. These therapies have revolutionized (TKIs), and cell surface-targeted monoclonal antibodies, medicine and offer targeted therapy for an including how to manage these reactions
    [Show full text]
  • Bacterial Infections Diseases Picture Cause Basic Lesion
    page: 117 Chapter 6: alphabetical Bacterial infections diseases picture cause basic lesion search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 118 6.1 Impetigo alphabetical Bullous impetigo Bullae with cloudy contents, often surrounded by an erythematous halo. These bullae rupture easily picture and are rapidly replaced by extensive crusty patches. Bullous impetigo is classically caused by Staphylococcus aureus. cause basic lesion Basic Lesions: Bullae; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 119 alphabetical Non-bullous impetigo Erythematous patches covered by a yellowish crust. Lesions are most frequently around the mouth. picture Lesions around the nose are very characteristic and require prolonged treatment. ß-Haemolytic streptococcus is cause most frequently found in this type of impetigo. basic lesion Basic Lesions: Erythematous Macule; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Ecthyma page: 120 6.2 Ecthyma alphabetical Slow and gradually deepening ulceration surmounted by a thick crust. The usual site of ecthyma are the legs. After healing there is a permanent scar. The pathogen is picture often a streptococcus. Ecthyma is very common in tropical countries. cause basic lesion Basic Lesions: Crusts; Ulcers Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Folliculitis page: 121 6.3 Folliculitis
    [Show full text]
  • Abscesses Are a Serious Problem for People Who Shoot Drugs
    Where to Get Your Abscess Seen Abscesses are a serious problem for people who shoot drugs. But what the hell are they and where can you go for care? What are abscesses? Abscesses are pockets of bacteria and pus underneath you skin and occasionally in your muscle. Your body creates a wall around the bacteria in order to keep the bacteria from infecting your whole body. Another name for an abscess is a “soft tissues infection”. What are bacteria? Bacteria are microscopic organisms. Bacteria are everywhere in our environment and a few kinds cause infections and disease. The main bacteria that cause abscesses are: staphylococcus (staff-lo-coc-us) aureus (or-e-us). How can you tell when you have an abscess? Because they are pockets of infection abscesses cause swollen lumps under the skin which are often red (or in darker skinned people darker than the surrounding skin) warm to the touch and painful (often VERY painful). What is the worst thing that can happen? The worst thing that can happen with abscesses is that they can burst under your skin and cause a general infection of your whole body or blood. An all over bacterial infection can kill you. Another super bad thing that can happen is a endocarditis, which is an infection of the lining of your heart, and “septic embolism”, which means that a lump of the contaminates in your abscess get loose in your body and lodge in your lungs or brain. Why do abscesses happen? Abscesses are caused when bad bacteria come in to contact with healthy flesh.
    [Show full text]
  • Cellulitis (You Say, Sell-You-Ly-Tis)
    Cellulitis (you say, sell-you-ly-tis) Any area of skin can become infected with cellulitis if the skin is broken, for example from a sore, insect bite, boil, rash, cut, burn or graze. Cellulitis can also infect the flesh under the skin if it is damaged or bruised or if there is poor circulation. Signs your child has cellulitis: The skin will look red, and feel warm and painful to touch. There may be pus or fluid leaking from the skin. The skin may start swelling. The red area keeps growing. Gently mark the edge of the infected red area How is with a pen to see if the red area grows bigger. cellulitis spread? Red lines may appear in the skin spreading out from the centre of the infection. Bad bacteria (germs) gets into broken skin such as a cut or insect bite. What to do Wash your hands before and Cellulitis is a serious infection that needs to after touching the infected area. be treated with antibiotics. Keep your child’s nails short and Go to the doctor if the infected area is clean. painful or bigger than a 10 cent piece. Don’t let your child share Go to the doctor immediately if cellulitis is bath water, towels, sheets and near an eye as this can be very serious. clothes. Make sure your child takes the antibiotics Make sure your child rests every day until they are finished, even if and eats plenty of fruit and the infection seems to have cleared up. The vegetables and drinks plenty of antibiotics need to keep killing the infection water.
    [Show full text]
  • 022291S015 Eltrombopag Clinical BPCA
    CLINICAL REVIEW Application Type sNDA Application Number(s) 022291, S-015 Priority or Standard Priority Submit Date(s) December 19, 2014 Received Date(s) December 19, 2014 PDUFA Goal Date June 19, 2015 Division / Office Division of Hematology Products/OHOP Reviewer Name(s) Lori A. Ehrlich Review Completion Date May 26, 2015 Established Name Eltrombopag Trade Name Promacta® Therapeutic Class Thrombopoietin Agonist Applicant Glaxo SmithKline Formulation(s) Tablet Dosing Regimen 50 mg once daily Indication(s) Chronic ITP Intended Population(s) Pediatric patients ≥6 years old with chronic ITP Template Version: March 6, 2009 Reference ID: 3765521 Clinical Review Lori A. Ehrlich, MD, PhD NDA 022291, S-015 Promacta® (eltrombopag) tablets Table of Contents 1 RECOMMENDATIONS/RISK BENEFIT ASSESSMENT ......................................... 8 1.1 Recommendation on Regulatory Action ............................................................. 8 1.2 Risk Benefit Assessment.................................................................................... 9 1.3 Recommendations for Postmarket Risk Evaluation and Mitigation Strategies . 11 1.4 Recommendations for Postmarket Requirements and Commitments .............. 11 2 INTRODUCTION AND REGULATORY BACKGROUND ...................................... 11 2.1 Product Information .......................................................................................... 12 2.2 Tables of Currently Available Treatments for Proposed Indications ................. 12 2.3 Availability of Proposed Active Ingredient
    [Show full text]
  • Skin Disease and Disorders
    Sports Dermatology Robert Kiningham, MD, FACSM Department of Family Medicine University of Michigan Health System Disclosures/Conflicts of Interest ◼ None Goals and Objectives ◼ Review skin infections common in athletes ◼ Establish a logical treatment approach to skin infections ◼ Discuss ways to decrease the risk of athlete’s acquiring and spreading skin infections ◼ Discuss disqualification and return-to-play criteria for athletes with skin infections ◼ Recognize and treat non-infectious skin conditions in athletes Skin Infections in Athletes ◼ Bacterial ◼ Herpetic ◼ Fungal Skin Infections in Athletes ◼ Very common – most common cause of practice-loss time in wrestlers ◼ Athletes are susceptible because: – Prone to skin breakdown (abrasions, cuts) – Warm, moist environment – Close contacts Cases 1 -3 ◼ 21 year old male football player with 4 day h/o left axillary pain and tenderness. Two days ago he noticed a tender “bump” that is getting bigger and more tender. ◼ 16 year old football player with 3 day h/o mildly tender lesions on chin. Started as a single lesion, but now has “spread”. Over the past day the lesions have developed a dark yellowish crust. ◼ 19 year old wrestler with a 3 day h/o lesions on right side of face. Noticed “tingling” 4 days ago, small fluid filled lesions then appeared that have now started to crust over. Skin Infections Bacterial Skin Infections ◼ Cellulitis ◼ Erysipelas ◼ Impetigo ◼ Furunculosis ◼ Folliculitis ◼ Paronychea Cellulitis Cellulitis ◼ Diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin – Triad of erythema, edema, and warmth in the absence of underlying foci ◼ S. aureus or S. pyogenes Erysipelas Erysipelas ◼ Superficial infection of the dermis ◼ Distinguished from cellulitis by the intracutaneous edema that produces palpable margins of the skin.
    [Show full text]
  • Jemds.Com Original Research Article
    Jemds.com Original Research Article DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE Parvaiz Anwar Rather1, M. Hussain Mir2, Sandeep Kaul3, Vikas Roshan4, Jilu Mathews5, Bandu Sharma6 1Lecturer, Department of Dermatology, GMC, Jammu, Jammu & Kashmir, India. 2Consultant, Department of Oncology, Narayana Superspeciality Hospital, Katra, Jammu, Jammu & Kashmir, India. 3Consultant, Department of Surgical Oncology, Narayana Superspeciality Hospital, Katra, Jammu, Jammu & Kashmir, India. 4Consultant, Department of Radiation Oncology, Narayana Superspeciality Hospital, Katra, Jammu, Jammu & Kashmir, India. 5Senior Nursing In Charge, Department of Oncology, Narayana Superspeciality Hospital, Katra, Jammu, Jammu & Kashmir, India. 6Senior Nursing In Charge, Department of Oncology, Narayana Superspeciality Hospital, Katra, Jammu, Jammu & Kashmir, India. ABSTRACT BACKGROUND Chemotherapeutic agents, both conventional and new targeted therapy, are known to cause diverse side effects related to skin, hair, mucous membranes and nails, collectively called `dermatological adverse effects`. But such association in literature is mostly confined to case reports/case series and small number of published papers. The aim of this study is to look for dermatological adverse effects and the most common culprit agents, with the objective that the oncologist and dermatologist team remain vigilant and adopt rational management protocol in their management to circumvent the morbidity and long-term toxicity as it involves the cosmetic appearance of long-term cancer survivor. MATERIALS AND METHODS This prospective hospital-based descriptive study was conducted jointly by the dermatologist and oncology team over a period of more than one year in a specialised tertiary centre on oncology patients, who developed dermatological side effects after initiation of anti-cancer drugs. RESULTS Out of 125 patients studied, dermatological adverse effects of varying duration were noticed in 27 patients (21.6%), with overall 45 side effects manifestation.
    [Show full text]
  • Factsheet Boils and Impetigo
    FACTSHEET BOILS AND IMPETIGO WHAT IS A BOIL? HOW CAN YOU STOP THE SPREAD OF BOILS A boil is an infection of the skin, usually caused by AND IMPETIGO? Staphylococcus bacteria. Boils are tender, swollen sores, Wash your hands which are full of pus. The tenderness usually goes away, Hand washing is the most important way to prevent the once the boil bursts and the pus and fluid drain. spread of boils and impetigo. Wash all parts of your hands (including between the fingers and under fingernails) WHAT IS IMPETIGO? vigorously with soap and running water for 10-15 seconds. Impetigo is an infection of the skin caused by either Rinse well and dry your hands (with a paper towel if you Staphylococcus or Streptococcus bacteria. The symptoms can). Wash your hands: of impetigo are either small blisters or flat, honey-coloured crusty sores, on the skin. Impetigo is sometimes called • before and after touching or dressing an infected area ‘school sores’. or wound; • after going to the toilet; HOW ARE BOILS AND IMPETIGO TREATED? • after blowing your nose; If you have the symptoms of boils or impetigo: • before handling or eating food; • see your doctor for advice on the treatment of both; • before handling newborn babies; • if sores are small or few, local antiseptic cream and hot • after touching or handling unwashed clothing or linen; compresses may help; • after handling animals or animal waste. • your doctor may prescribe you antibiotic tablets or Cover boils and impetigo ointment. It is important to take the full course of antibiotics. If you don’t, the sores may come back.
    [Show full text]
  • Drug-Induced Acneiform Eruptions
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE We are IntechOpen, provided by IntechOpen the world’s leading publisher of Open Access books Built by scientists, for scientists 4,800 122,000 135M Open access books available International authors and editors Downloads Our authors are among the 154 TOP 1% 12.2% Countries delivered to most cited scientists Contributors from top 500 universities Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI) Interested in publishing with us? Contact [email protected] Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com Chapter 5 Drug-Induced Acneiform Eruptions Emin Özlü and Ayşe Serap Karadağ EminAdditional Özlü information and Ayşe is available Serap at Karadağ the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/65634 Abstract Acne vulgaris is a chronic skin disease that develops as a result of inflammation of the pilosebaceous unit and its clinical course is accompanied by comedones, papules, pus- tules, and nodules. A different group of disease, which is clinically similar to acne vul- garis but with a different etiopathogenesis, is called “acneiform eruptions.” In clinical practice, acneiform eruptions are generally the answer of the question “What is it if it is not an acne?” Although there are many subgroups of acneiform eruptions, drugs are common cause of acneiform eruptions, and this clinical picture is called “drug-induced acneiform eruptions.” There are many drugs related to drug-induced acneiform erup- tions.
    [Show full text]